Insider · CIK 0001872827
Tilak Mandadi
Files at CVS (CVS HEALTH Corp). First filing May 11, 2026, latest May 11, 2026.
In brief
Tilak Mandadi files SEC Form 4 as officer at CVS (CVS HEALTH Corp). Since May 11, 2026, Tilak Mandadi has reported 0 open-market buys worth $0 and 1 open-market sell worth $6.2M, the latest filed on May 11, 2026.
A track record needs three past buys with six months of prices behind them; Tilak Mandadi has 0, so none is measured yet.
The newest scored trade: sold $6.2M of CVS on May 8, 2026, filed May 11, 2026, scored 68 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $6.2M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CVS: CVS HEALTH Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | CVS HEALTH Corp | $6.2M 69,551 shares | -87% | +58% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 8, 2026 | CVS CVS HEALTH CORPORATION | 69,551 0.01% of outstanding | $6.2M | May 8, 2026 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | CVS CVS HEALTH Corp | SOpen-market sale Common Stock | -69,551 | $89.58 | $6.2M | 10,133 | May 11, 2026 |
| Mar 31, 2026 | CVS CVS HEALTH Corp | AGrant or award Common Stock (RSUs) | +22,277 | $71.82 | $1.6M | 88,543 | Apr 2, 2026 |
| Apr 1, 2026 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -3,634 | $72.49 | $263k | 79,684 | Apr 2, 2026 |
| Mar 31, 2026 | CVS CVS HEALTH Corp | AGrant or award Stock Optionderivative | +143,712 | $71.82 | $10M | 143,712 | Apr 2, 2026 |
| Nov 30, 2025 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -6,575 | $80.36 | $528k | 74,085 | Dec 2, 2025 |
| Aug 31, 2025 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -12,834 | $73.15 | $939k | 63,952 | Sep 2, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -995 | $67.98 | $68k | 43,503 | Apr 3, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | AGrant or award Common Stock (RSU) | +20,594 | $67.98 | $1.4M | 116,257 | Apr 3, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | AGrant or award Stock Optionderivative | +87,336 | $67.98 | $5.9M | 87,336 | Apr 3, 2025 |
| Nov 30, 2024 | CVS CVS HEALTH Corp | AGrant or award Common Stock (RSU) | +50,125 | $59.85 | $3.0M | 99,747 | Dec 3, 2024 |
Questions about Tilak Mandadi
Answered from the filings on this page, as of the latest one.
Is Tilak Mandadi buying or selling?
In the last 12 months Tilak Mandadi reported 0 open-market buys worth $0 and 1 open-market sell worth $6.2M on SEC Form 4; the latest was sold $6.2M of CVS on May 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Tilak Mandadi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tilak Mandadi has 0.
Where does Tilak Mandadi file Form 4?
Tilak Mandadi has filed Form 4 at CVS (CVS HEALTH Corp) as EVP, Chief Exp & Tech Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.